D. Barbo William's most recent trade in Charles River Laboratories International Inc. was a trade of 470 Common Stock done . Disclosure was reported to the exchange on Nov. 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Nov 2024 | 470 | 23,337 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 29 May 2024 | 179 | 3,433 (0%) | 0% | 214.5 | 38,397 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 177 | 3,821 (0%) | 0% | 217.2 | 38,446 | Common Stock |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2024 | 177 | 3,858 (0%) | 0% | 217.2 | 38,446 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2024 | 147 | 3,711 (0%) | 0% | 217.2 | 31,930 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 132 | 3,689 (0%) | 0% | 217.2 | 28,672 | Common Stock |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2024 | 99 | 3,612 (0%) | 0% | 217.2 | 21,504 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 84 | 3,605 (0%) | 0% | 217.2 | 18,246 | Common Stock |
| Charles River Laboratories... | D. Barbo William | Corporate Executive VP & CCO | 22 Feb 2024 | 4,050 | 22,879 (0%) | 0% | 248.5 | 1,006,425 | Common Stock | |
| Charles River Laboratories... | William Barbo D. | Corporate Executive VP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 2,997 | 12,100 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 29 Jan 2024 | 2,934 | 12,037 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William Barbo D. | Corporate Executive VP & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 770 | 11,330 (0%) | 0% | 220.3 | 169,616 | Common Stock |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 29 Jan 2024 | 744 | 11,293 (0%) | 0% | 220.3 | 163,888 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 10 Aug 2023 | 5,763 | 3,592 (0%) | 0% | 217.2 | 1,251,954 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 10 Aug 2023 | 5,511 | 0 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 10 Aug 2023 | 5,511 | 9,103 (0%) | 0% | 144.7 | 797,276 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2023 | 4,696 | 4,696 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2023 | 1,958 | 10,434 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2023 | 202 | 9,954 (0%) | 0% | 194.1 | 39,212 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2023 | 166 | 10,268 (0%) | 0% | 194.1 | 32,224 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 26 May 2023 | 112 | 10,156 (0%) | 0% | 194.1 | 21,741 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 22 Feb 2023 | 287 | 8,476 (0%) | 0% | 243.6 | 69,913 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 27 Jan 2023 | 7,857 | 11,660 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 27 Jan 2023 | 2,897 | 8,763 (0%) | 0% | 244.3 | 707,708 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 3,205 | 7,008 (0%) | 0% | 109.3 | 350,435 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 3,205 | 0 | - | - | Stock Options | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 1,226 | 4,503 (0%) | 0% | 220.1 | 269,892 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 873 | 5,729 (0%) | 0% | 219.4 | 191,549 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 700 | 3,803 (0%) | 0% | 221.1 | 154,753 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 406 | 6,602 (0%) | 0% | 218.3 | 88,621 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 391 | 19,235 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 391 | 3,803 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 07 Jun 2022 | 200 | 19,035 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 4,036 | 4,036 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 1,493 | 4,508 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 754 | 3,015 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 754 | 18,844 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 202 | 4,194 (0%) | 0% | 244.4 | 49,371 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 11 Mar 2022 | 112 | 4,396 (0%) | 0% | 244.4 | 27,374 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 08 Feb 2022 | 6,178 | 4,371 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 08 Feb 2022 | 6,178 | 18,090 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 08 Feb 2022 | 315 | 3,769 (0%) | 0% | 289.6 | 91,218 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 08 Feb 2022 | 287 | 4,084 (0%) | 0% | 293.6 | 84,266 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 01 Dec 2021 | 10,273 | 14,644 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 01 Dec 2021 | 4,095 | 10,549 (0%) | 0% | 312.2 | 1,278,623 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 01 Dec 2021 | 400 | 11,912 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 3,253 | 10,561 (0%) | 0% | 401.6 | 1,306,483 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 3,204 | 3,205 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 3,204 | 12,490 (0%) | 0% | 109.3 | 350,325 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 2,944 | 13,814 (0%) | 0% | 400.8 | 1,180,045 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 2,755 | 5,511 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 2,755 | 15,245 (0%) | 0% | 144.7 | 398,566 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 2,380 | 8,181 (0%) | 0% | 402.6 | 958,293 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 1,685 | 5,078 (0%) | 0% | 405.6 | 683,398 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 1,513 | 4,541 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 1,513 | 16,758 (0%) | 0% | 179.7 | 271,826 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 726 | 7,455 (0%) | 0% | 403.6 | 293,012 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 692 | 6,763 (0%) | 0% | 404.8 | 280,134 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 500 | 4,571 (0%) | 0% | 407.4 | 203,724 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 252 | 4,371 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 252 | 12,312 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 200 | 4,371 (0%) | 0% | 409.1 | 81,816 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 09 Jun 2021 | 7 | 5,071 (0%) | 0% | 406.6 | 2,846 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 28 May 2021 | 3,110 | 3,110 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 28 May 2021 | 1,006 | 4,824 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 28 May 2021 | 201 | 4,623 (0%) | 0% | 338.0 | 67,936 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 3,493 | 3,818 (0%) | 0% | 290.1 | 1,013,312 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 3,493 | 0 | - | - | Stock Options (Right to Buy) | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 3,493 | 7,311 (0%) | 0% | 88.1 | 307,559 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 1,157 | 18,132 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 1,157 | 16,975 (0%) | 0% | 290.4 | 336,028 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 25 Feb 2021 | 1,157 | 3,818 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 24 Feb 2021 | 322 | 4,975 (0%) | 0% | 283.0 | 91,120 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 04 Feb 2021 | 7,154 | 5,899 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 04 Feb 2021 | 7,154 | 16,975 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 04 Feb 2021 | 315 | 5,297 (0%) | 0% | 283.6 | 89,331 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 04 Feb 2021 | 287 | 5,612 (0%) | 0% | 289.6 | 83,101 | Common Stock | |
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 02 Feb 2021 | 11,862 | 17,761 (0%) | 0% | 0 | Common Stock | ||
| Charles River Laboratories... | William D. Barbo | Corporate Executive VP & CCO | 02 Feb 2021 | 4,708 | 13,053 (0%) | 0% | 260.9 | 1,228,223 | Common Stock |